ELLEN LUCCA: Open Payments
NPI 1023652070 · HAWLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 45 payments from 11 companies in 2025. Trend: 2023 $1,210 · 2024 $787 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $225 |
| ABBVIE INC. | 6 | $150 |
| Otsuka America Pharmaceutical, Inc. | 3 | $141 |
| Novo Nordisk Inc | 9 | $139 |
| Astellas Pharma US Inc | 6 | $125 |
| Tandem Diabetes Care, Inc. | 4 | $94 |
| PFIZER INC. | 4 | $73 |
| Dexcom, Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $33 |
Products named: AIRSUPRA, REXULTI, Veozah, t:slim X2 Insulin Pump with Control-IQ, VRAYLAR, Wegovy, ELIQUIS, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
